Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Fatigue 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Brain Diseases 1Anxiety Disorders 1

Interventions

Methylphenidate 6Modafinil 5Surveys and Questionnaires 3Acupuncture Therapy 3Yoga 2Therapeutics 2regorafenib 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1Water 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Sunitinib 1Standard of Care 1Sodium Chloride 1Radiotherapy 1Neurofeedback 1Midazolam 1Methods 1Mental Status and Dementia Tests 1Lactose 1Ketamine 1Infliximab 1Exercise Therapy 1Exercise 1Escitalopram 1Early Intervention, Educational 1Dextromethorphan 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Fatigue × Midazolam × Clear all
NCT02317341 2019-03-20

Effect of Ketamine on Fatigue Following Cancer Therapy

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
2 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡